Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat life-threatening infections. The Company... Read more
MarketWatch
Yahoo
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.